Home › Funds › Taikang Asset Management (Hong Kong) Co Ltd › IQV

Taikang Asset Management (Hong Kong) Co Ltd position in IQV

IQVIA HLDGS INC · Health Care

Taikang Asset Management (Hong Kong) Co Ltd reported holding 33,749 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$9.1M, representing 0.81% of its reported portfolio and ranking #50 among its reported holdings. Taikang Asset Management (Hong Kong) Co Ltd has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)33.75K sh
Reported value held$9.07M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Taikang Asset Management (Hong Kong) Co Ltd's IQV position evolved

Taikang Asset Management (Hong Kong) Co Ltd first disclosed a stake in IQV in Q3 2023 at 12,101 shares (US$19K). The position peaked in Q2 2026 at 66,542 shares, worth US$12.9M. Across 13 filings, Taikang Asset Management (Hong Kong) Co Ltd increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 33,749 shares valued at US$9.1M — a reduction of -32,793 shares quarter over quarter.. Notable position changes include a 66% increase in Q2 2024 (shares rose 12% over the following quarter), a 54% increase in Q2 2025 (shares rose 21% over the following quarter), a 49% trim in Q3 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.10K $18.65K New
Q4 2023 13.39K $3.10M Add
Q1 2024 14.89K $3.77M Add
Q2 2024 24.69K $5.22M Add
Q3 2024 35.49K $8.41M Add
Q4 2024 26.94K $5.29M Reduce
Q1 2025 29.46K $5.19M Add
Q2 2025 45.32K $7.14M Add
Q3 2025 41.73K $7.93M Reduce
Q4 2025 46.54K $10.49M Add
Q1 2026 61.84K $10.55M Add
Q2 2026 66.54K $12.86M Add
Q3 2026 33.75K $9.07M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IQV and 13F data

IQV (IQVIA HLDGS INC) is a Health Care company. 25 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IQV

All IQV fund holders →

FAQ

How long has Taikang Asset Management (Hong Kong) Co Ltd held IQV?

Taikang Asset Management (Hong Kong) Co Ltd has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Taikang Asset Management (Hong Kong) Co Ltd's current position in IQV?

As of Q3 2026, Taikang Asset Management (Hong Kong) Co Ltd holds 33.75K shares of IQV (IQVIA HLDGS INC), valued at $9.07M, representing 0.81% of its reported portfolio and ranking #50.

Has Taikang Asset Management (Hong Kong) Co Ltd been buying or selling IQV?

In the latest 13F filing (Q3 2026), Taikang Asset Management (Hong Kong) Co Ltd reduced its position in IQV. The position peaked in Q2 2026 at 66.54K shares.

Which other funds hold IQV?

Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.